comparemela.com
Home
Live Updates
Robertf Hauser - Breaking News
Pages:
Robertf Hauser News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Inhibikase Therapeutics to Host Virtual KOL Investor Event on April 20, 2022
/PRNewswire/ Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing therapeutics to modify.
United states
Robertf hauser
Miltonh werner
Alex lobo
Werner poewe
Inhibikase therapeutics inc
Company contact
Parkinson movement disorder center
Inhibikase or company
Prnewswire inhibikase therapeutics inc
Sternir inc
Movement disorder center
Medicine neurology
South florida
Innsbruck medical university
Abelson tyrosine kinase
vimarsana © 2020. All Rights Reserved.